New Deal
Andrew Funderburk
Managing Director at Kendall Investor Relations
PR Consultant
Deal Bio
Repertoire Immune Medicines
Flagship Pioneering
£137m
17 dealmakers
Voyager Therapeutics
Neurocrine Biosciences
£144m
8 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.